Aazami Matthias, Schäfers Hans-Joachim
Department of Thoracic and Cardiovascular Surgery, University Hospitals, University of Saarland, Homburg/Saar, Germany.
J Interv Cardiol. 2003 Dec;16(6):535-41. doi: 10.1046/j.1540-8183.2003.01053.x.
Heart valve surgery continues to evolve in a dynamic fashion. While the exact role of minimally invasive approaches still needs to be defined, progress has been made in the development of new bioprostheses and their durability. Most importantly, valve repair has been standardized for the mitral and introduced for the aortic valve with results that have been superior to valve replacement. Selection of the optimal procedure for the individual patient is now facilitated. In the future, a wider application of repair procedures and further improvements of biologic valves can be anticipated not only to influence long-term results but also the decision-making process for conservative or surgical treatment.
心脏瓣膜手术仍在以动态的方式不断发展。虽然微创方法的确切作用仍有待明确,但新型生物假体的研发及其耐久性方面已取得进展。最重要的是,二尖瓣修复已实现标准化,主动脉瓣修复也已开展,其效果优于瓣膜置换。现在为个体患者选择最佳手术方式变得更加容易。未来,可以预期修复手术将得到更广泛应用,生物瓣膜也会进一步改进,这不仅会影响长期效果,还会影响保守治疗或手术治疗的决策过程。